Sleeve Gastrectomy With Cruroplasty and Omental Rape for Treatment of Morbid Obesity With Reflux Disease

Obesity, Morbid Clinical Trial

Official title:

Sleeve Gastrectomy With Cruroplasty and Omental Rape for Treatment of Morbid Obesity With Reflux Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05590208
• Other study ID #: fac.med 22.64
• Status: Completed
• Phase: N/A
• Start date: October 12, 2022
• Est. completion date: December 20, 2023

Study information

• Verified date: December 2022
• Source: Minia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

in this study the investigators will test anew technique to mange patients with morbid obesity and GERD by doing sleeve gastrectomy plus cruroplasty and omental rape around the gastroesophageal junction

Description:

in this study the patients that have morbid obesity concomitant GERD will managed by sleeve gastrectomy plus cruroplasty then stripe from the momentum is fashioned and is raped around the gastroesophageal junction

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: December 20, 2023
• Est. primary completion date: December 20, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity

• patients fit for laparoscopic surgery

• give approval to share in the study

Exclusion Criteria:

• patients refused to share in the study

• patients unfit for surgery

• patients aged less than 18 and older than 60

• patient with previous upper abdominal surgery either for obesity or other diseases

• revisional bariatric procedures

Related Conditions & MeSH terms

• GERD
• Obesity
• Obesity, Morbid

Intervention

Procedure:
• sleeve gastrectomy+ cruroplasty+ omental rap
sleeve gastrectomy+ cruroplasty+ omental rap

Locations

Country	Name	City	State
Egypt	Minia university hospital	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the effect on GERD	change in GERD symptoms using either upper GIT endoscopy or GERDQ questionnaire	6 months
Secondary	weight loss	the effect on weight loss determined by percentage of excess weight loss, percentage of total weight loss and change of BMI	12 months
Secondary	comorbidities	change in comorbidities including diabetes by change in hemoglobin C level, hypertension by measuring arterial blood pressure using sphygmomanometer	12 months